Morgan Stanley Avanos Medical, Inc. Call Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AVNS
# of Institutions
276Shares Held
42.5MCall Options Held
5.4KPut Options Held
5K-
Black Rock Inc. New York, NY7.01MShares$134 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$102 Million0.0% of portfolio
-
Rgm Capital, LLC Naples, FL3.17MShares$60.8 Million3.28% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$49.6 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.37MShares$45.4 Million0.03% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $891M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...